COX-2 use grows despite little added benefit over NSAIDs

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1037, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 use grows despite little added benefit over NSAIDs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

COX-2 use grows despite little added benefit over NSAIDs

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

COX-2s preferred over nonselective NSAIDs in coumarin recipients

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*

By Gunnarsdóttir Anna Kinnear Moira

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 316-320

Springer Publishing Company

Access to resources Recommend Favorite

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite